Online PLR Content Directory Canada: 2011

Tuesday 6 December 2011

Foligan

Foligan may be available in the countries listed below.

Ingredient matches for Foligan

Allopurinol

Allopurinol is reported as an ingredient of Foligan in the following countries:

Germany

International Drug Name Search

Saturday 3 December 2011

Umbra MD

Umbra MD may be available in the countries listed below.

Ingredient matches for Umbra MD

Barium Sulfate

Barium Sulfate is reported as an ingredient of Umbra MD in the following countries:

Japan

International Drug Name Search

Saturday 5 November 2011

Bevonazole

Bevonazole may be available in the countries listed below.

Ingredient matches for Bevonazole

Itraconazole

Itraconazole is reported as an ingredient of Bevonazole in the following countries:

Greece

International Drug Name Search

Thursday 27 October 2011

Metadaxan

Metadaxan may be available in the countries listed below.

Ingredient matches for Metadaxan

Dexamethasone

Dexamethasone 21-(disodium phosphate) (a derivative of Dexamethasone) is reported as an ingredient of Metadaxan in the following countries:

Bangladesh

International Drug Name Search

Wednesday 26 October 2011

Efcortelan Soluble

Efcortelan Soluble may be available in the countries listed below.

Ingredient matches for Efcortelan Soluble

Hydrocortisone

Hydrocortisone 21-(sodium succinate) (a derivative of Hydrocortisone) is reported as an ingredient of Efcortelan Soluble in the following countries:

Bahrain

Iran

Kuwait

Qatar

United Arab Emirates

International Drug Name Search

Monday 24 October 2011

MPA-beta

MPA-beta may be available in the countries listed below.

Ingredient matches for MPA-beta

Medroxyprogesterone

Medroxyprogesterone 17α-acetate (a derivative of Medroxyprogesterone) is reported as an ingredient of MPA-beta in the following countries:

Germany

International Drug Name Search

Friday 21 October 2011

Zecef

Zecef may be available in the countries listed below.

Ingredient matches for Zecef

Cefradine

Cefradine is reported as an ingredient of Zecef in the following countries:

Bangladesh

International Drug Name Search

Monday 17 October 2011

Codeinã Fosforicã

Codeinã Fosforicã may be available in the countries listed below.

Ingredient matches for Codeinã Fosforicã

Codeine

Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Codeinã Fosforicã in the following countries:

Romania

International Drug Name Search

Delonide

Generic Name: desonide topical (DES oh nide)

Brand Names: Delonide, Desonate, DesOwen, DesOwen 2 oz, DesOwen Lotion 4 oz Kit, LoKara, Tridesilon, Verdeso

What is Delonide (desonide topical)?

Desonide is a topical (for the skin) steroid. It reduces the actions of chemicals in the body that cause inflammation, redness, and swelling.

Desonide topical is used to treat the inflammation and itching caused by a number of skin conditions such as allergic reactions, eczema, and psoriasis.

Desonide topical may also be used for other purposes not listed in this medication guide.

What is the most important information I should know about Delonide (desonide topical)?

Use this medication exactly as directed on the label, or as it has been prescribed by your doctor. Do not use the medication in larger amounts or for longer than recommended. Topical steroid medicine can be absorbed through the skin, which may cause steroid side effects throughout the body.

Do not cover treated skin areas with a bandage or other covering unless your doctor has told you to. If you are treating the diaper area of a baby, do not use plastic pants or tight-fitting diapers. Covering the skin that is treated with desonide topical can increase the amount of medicine your skin absorbs, which may lead to unwanted side effects. Follow your doctor's instructions. Do not use this medication on a child without a doctor's advice. Children are more likely to absorb large amounts of a topical steroid through the skin. Steroid absorption in children may cause unwanted side effects, or a delay in growth with long-term use. Talk with your doctor if you think your child is not growing at a normal rate while using this medication over a long treatment period. Contact your doctor if your condition does not improve after 2 weeks of using this medicine, or if you develop signs of a bacterial, fungal, or viral skin infection.

What should I discuss with my healthcare provider before using Delonide (desonide topical)?

Do not use this medication if you are allergic to desonide.

Before using desonide topical, tell your doctor if you are allergic to any drugs, or if you have any type of skin infection.

Also tell your doctor if you have diabetes. Topical steroid medicines absorbed through the skin may increase the glucose (sugar) levels in your blood or urine.

FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether desonide topical passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. Do not use this medication on a child without a doctor's advice. Children are more likely to absorb large amounts of a topical steroid through the skin. Steroid absorption in children may cause unwanted side effects, or a delay in growth with long-term use. Talk with your doctor if you think your child is not growing at a normal rate while using this medication over a long treatment period.

How should I use Delonide (desonide topical)?

Wash your hands before and after using desonide topical, unless you are using the medication to treat the skin on your hands.

Apply a small amount to the affected area and rub it gently into the skin. Do not use this medication over a large area of skin.

To be sure this medication is not causing harmful effects with long-term use, you may need blood tests. Do not miss any scheduled appointments.

Store desonide topical at room temperature away from moisture and heat. Keep from freezing.

What happens if I miss a dose?

Use the medication as soon as you remember. If it is almost time for the next dose, skip the missed dose and use the medicine at the next regularly scheduled time. Do not use extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention if you think you have used too much of this medicine.

An overdose of desonide is not expected to produce life-threatening symptoms. However, long-term use of high steroid doses can lead to symptoms such as thinning skin, easy bruising, changes in the shape or location of body fat (especially in your face, neck, back, and waist), increased acne or facial hair, menstrual problems, impotence, or loss of interest in sex.

What should I avoid while using Delonide (desonide topical)?

Desonide topical should not be used to treat any skin condition your doctor has not prescribed it for.

Avoid getting this medication in your eyes. If contact does occur, rinse with water. Do not use desonide topical on broken or infected skin. Also avoid using this medication in open wounds.

Delonide (desonide topical) side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using this medication and call your doctor at once if you have severe irritation of any treated skin, or if you show signs of absorbing desonide topical through your skin, such as:

blurred vision, or seeing halos around lights;

mood changes;

sleep problems (insomnia);

weight gain, puffiness in your face; or

muscle weakness, feeling tired.

Less serious side effects may include:

mild skin itching, redness, burning, or peeling;

dryness or scaly skin;

thinning or softening of your skin;

skin rash or irritation around your mouth;

swollen hair follicles;

changes in color of treated skin;

blisters, pimples, or crusting of treated skin; or

stretch marks.

This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Delonide (desonide topical)?

It is not likely that other drugs you take orally or inject will have an effect on topically applied desonide topical. But many drugs can interact with each other. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.

More Delonide resources

Delonide Side Effects (in more detail)
Delonide Use in Pregnancy & Breastfeeding
Delonide Drug Interactions
Delonide Support Group
0 Reviews for Delonide - Add your own review/rating

DesOwen Cream MedFacts Consumer Leaflet (Wolters Kluwer)

DesOwen Cream Kit Cream MedFacts Consumer Leaflet (Wolters Kluwer)

Desonate Consumer Overview

Desonate Advanced Consumer (Micromedex) - Includes Dosage Information

Desonate Gel MedFacts Consumer Leaflet (Wolters Kluwer)

Desonate Prescribing Information (FDA)

Desowen Prescribing Information (FDA)

LoKara Prescribing Information (FDA)

LoKara Lotion MedFacts Consumer Leaflet (Wolters Kluwer)

Verdeso Prescribing Information (FDA)

Verdeso Consumer Overview

Verdeso Foam MedFacts Consumer Leaflet (Wolters Kluwer)

Compare Delonide with other medications

Atopic Dermatitis
Dermatitis
Eczema
Psoriasis

Where can I get more information?

Your pharmacist can provide more information about desonide topical.

See also: Delonide side effects (in more detail)

Tuesday 11 October 2011

Revitalose-C-1000

Generic Name: ascorbic acid (Oral route)

as-KORE-bik AS-id

Commonly used brand name(s)

In the U.S.

Ascocid

C-500

Cecon

Cemill 1000

Cemill 500

Cevi-Bid

C-Time w/Rose Hips

Mega-C

One-Gram C

Protexin

Sunkist Vitamin C

In Canada

Ce-Vi-Sol

Revitalose-C-1000

Revitonus C-1000 Yellow Ampule

Vitamin C Powder

Available Dosage Forms:

Tablet

Powder

Powder for Solution

Capsule, Liquid Filled

Tablet, Chewable

Granule

Capsule

Syrup

Powder for Suspension

Liquid

Solution

Tablet, Extended Release

Lozenge/Troche

Capsule, Extended Release

Wafer

Therapeutic Class: Nutritive Agent

Pharmacologic Class: Vitamin C

Uses For Revitalose-C-1000

Vitamins are compounds that you must have for growth and health. They are needed in small amounts only and are usually available in the foods that you eat. Ascorbic acid, also known as vitamin C, is necessary for wound healing. It is needed for many functions in the body, including helping the body use carbohydrates, fats, and protein. Vitamin C also strengthens blood vessel walls.

Lack of vitamin C can lead to a condition called scurvy, which causes muscle weakness, swollen and bleeding gums, loss of teeth, and bleeding under the skin, as well as tiredness and depression. Wounds also do not heal easily. Your health care professional may treat scurvy by prescribing vitamin C for you.

Some conditions may increase your need for vitamin C. These include:

AIDS (acquired immune deficiency syndrome)

Alcoholism

Burns

Cancer

Diarrhea (prolonged)

Fever (prolonged)

Infection (prolonged)

Intestinal diseases

Overactive thyroid (hyperthyroidism)

Stomach ulcer

Stress (continuing)

Surgical removal of stomach

Tuberculosis

Also, the following groups of people may have a deficiency of vitamin C:

Infants receiving unfortified formulas

Smokers

Patients using an artificial kidney (on hemodialysis)

Patients who undergo surgery

Individuals who are exposed to long periods of cold temperatures

Increased need for vitamin C should be determined by your health care professional.

Vitamin C may be used for other conditions as determined by your health care professional.

Claims that vitamin C is effective for preventing senility and the common cold, and for treating asthma, some mental problems, cancer, hardening of the arteries, allergies, eye ulcers, blood clots, gum disease, and pressure sores have not been proven. Although vitamin C is being used to reduce the risk of cardiovascular disease and certain types of cancer, there is not enough information to show that these uses are effective.

Injectable vitamin C is given by or under the supervision of a health care professional. Other forms of vitamin C are available without a prescription.

Once a medicine or dietary supplement has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, vitamin C is used in certain patients with the following medical conditions:

Overdose of iron (to help another drug in decreasing iron levels in the body)

Methemoglobinemia (a blood disease)

Importance of Diet

For good health, it is important that you eat a balanced and varied diet. Follow carefully any diet program your health care professional may recommend. For your specific dietary vitamin and/or mineral needs, ask your health care professional for a list of appropriate foods. If you think that you are not getting enough vitamins and/or minerals in your diet, you may choose to take a dietary supplement.

Vitamin C is found in various foods, including citrus fruits (oranges, lemons, grapefruit), green vegetables (peppers, broccoli, cabbage), tomatoes, and potatoes. It is best to eat fresh fruits and vegetables whenever possible since they contain the most vitamins. Food processing may destroy some of the vitamins. For example, exposure to air, drying, salting, or cooking (especially in copper pots), mincing of fresh vegetables, or mashing potatoes may reduce the amount of vitamin C in foods. Freezing does not usually cause loss of vitamin C unless foods are stored for a very long time.

Vitamins alone will not take the place of a good diet and will not provide energy. Your body also needs other substances found in food such as protein, minerals, carbohydrates, and fat. Vitamins themselves often cannot work without the presence of other foods.

The daily amount of vitamin C needed is defined in several different ways.

For U.S.—

Recommended Dietary Allowances (RDAs) are the amount of vitamins and minerals needed to provide for adequate nutrition in most healthy persons. RDAs for a given nutrient may vary depending on a person's age, sex, and physical condition (e.g., pregnancy).

Daily Values (DVs) are used on food and dietary supplement labels to indicate the percent of the recommended daily amount of each nutrient that a serving provides. DV replaces the previous designation of United States Recommended Daily Allowances (USRDAs).

For Canada—

Recommended Nutrient Intakes (RNIs) are used to determine the amounts of vitamins, minerals, and protein needed to provide adequate nutrition and lessen the risk of chronic disease.

Normal daily recommended intakes for vitamin C are generally defined as follows:

Persons	U.S. (mg)	Canada (mg)
Infants and children Birth to 3 years of age	30–40	20
4 to 6 years of age	45	25
7 to 10 years of age	45	25
Adolescent and adult males	50–60	25–40
Adolescent and adult females	50–60	25–30
Pregnant females	70	30–40
Breast-feeding females	90–95	55
Smokers	100	45–60

Before Using Revitalose-C-1000

If you are taking this dietary supplement without a prescription, carefully read and follow any precautions on the label. For this supplement, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Problems in children have not been reported with intake of normal daily recommended amounts.

Geriatric

Problems in older adults have not been reported with intake of normal daily recommended amounts.

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	C	Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding

Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this dietary supplement, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using this dietary supplement with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

Amygdalin

Deferoxamine

Using this dietary supplement with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

Indinavir

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Proper Use of ascorbic acid

This section provides information on the proper use of a number of products that contain ascorbic acid. It may not be specific to Revitalose-C-1000. Please read with care.

Dosing

The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

For oral dosage form (capsules, tablets, oral solution, syrup):
- To prevent deficiency, the amount taken by mouth is based on normal daily recommended intakes:
  - For the U.S.
  - Adult and teenage males—50 to 60 milligrams (mg) per day.
  - Adult and teenage females—50 to 60 mg per day.
  - Pregnant females—70 mg per day.
  - Breast-feeding females—90 to 95 mg per day.
  - Smokers—100 mg per day.
  - Children 4 to 10 years of age—45 mg per day.
  - Children birth to 3 years of age—30 to 40 mg per day.
  - For Canada
  - Adult and teenage males—25 to 40 mg per day.
  - Adult and teenage females—25 to 30 mg per day.
  - Pregnant females—30 to 40 mg per day.
  - Breast-feeding females—55 mg per day.
  - Smokers—45 to 60 mg per day.
  - Children 4 to 10 years of age—25 mg per day.
  - Children birth to 3 years of age—20 mg per day.
- To treat deficiency:
  - Adults and teenagers—Treatment dose is determined by prescriber for each individual based on the severity of deficiency. The following dose has been determined for scurvy: 500 mg a day for at least 2 weeks.
  - Children—Treatment dose is determined by prescriber for each individual based on the severity of deficiency. The following dose has been determined for scurvy: 100 to 300 mg a day for at least 2 weeks.

For those individuals taking the oral liquid form of vitamin C:

This preparation is to be taken by mouth even though it comes in a dropper bottle.

This dietary supplement may be dropped directly into the mouth or mixed with cereal, fruit juice, or other food.

Missed Dose

If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.

If you miss taking a vitamin for one or more days there is no cause for concern, since it takes some time for your body to become seriously low in vitamins.

Storage

Store the dietary supplement in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Precautions While Using Revitalose-C-1000

Vitamin C is not stored in the body. If you take more than you need, the extra vitamin C will pass into your urine. Very large doses may also interfere with tests for sugar in diabetics and with tests for blood in the stool.

Revitalose-C-1000 Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor as soon as possible if any of the following side effects occur:

Less common or rare - with high doses

Side or lower back pain

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common or rare - with high doses

Diarrhea

dizziness or faintness (with the injection only)

flushing or redness of skin

headache

increase in urination (mild)

nausea or vomiting

stomach cramps

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Revitalose-C-1000 side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More Revitalose-C-1000 resources

Revitalose-C-1000 Side Effects (in more detail)
Revitalose-C-1000 Use in Pregnancy & Breastfeeding
Revitalose-C-1000 Drug Interactions
Revitalose-C-1000 Support Group
0 Reviews for Revitalose-C-1000 - Add your own review/rating

Compare Revitalose-C-1000 with other medications

Dietary Supplementation
Scurvy
Urinary Acidification

Friday 16 September 2011

Bluxantron

Bluxantron may be available in the countries listed below.

Ingredient matches for Bluxantron

Mitoxantrone

Mitoxantrone is reported as an ingredient of Bluxantron in the following countries:

Ecuador

International Drug Name Search

Monday 12 September 2011

Genesis Drench with Selenium

Genesis Drench with Selenium may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Genesis Drench with Selenium

Ivermectin

Ivermectin is reported as an ingredient of Genesis Drench with Selenium in the following countries:

Australia

Sodium Selenate

Sodium Selenate is reported as an ingredient of Genesis Drench with Selenium in the following countries:

Australia

International Drug Name Search

Friday 9 September 2011

Winfinas

Winfinas may be available in the countries listed below.

Ingredient matches for Winfinas

Finasteride

Finasteride is reported as an ingredient of Winfinas in the following countries:

Czech Republic

International Drug Name Search

Tuesday 6 September 2011

Oxazepam AL

Oxazepam AL may be available in the countries listed below.

Ingredient matches for Oxazepam AL

Oxazepam

Oxazepam is reported as an ingredient of Oxazepam AL in the following countries:

Germany

International Drug Name Search

Neoplasia Medications

Topics under Neoplasia

Neoplasia, Estrogen Dependent (0 drugs)

Drug List:

Thursday 1 September 2011

Carvidon

Carvidon may be available in the countries listed below.

Ingredient matches for Carvidon

Trimetazidine

Trimetazidine dihydrochloride (a derivative of Trimetazidine) is reported as an ingredient of Carvidon in the following countries:

Myanmar

International Drug Name Search

Friday 26 August 2011

Seroxat

Seroxat may be available in the countries listed below.

UK matches:

Seroxat 10mg, 20mg, 30mg tablets, 20mg/10ml oral suspension (SPC)

Ingredient matches for Seroxat

Paroxetine

Paroxetine is reported as an ingredient of Seroxat in the following countries:

Latvia

Taiwan

Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Seroxat in the following countries:

Austria

Bahrain

Belgium

Bosnia & Herzegowina

Bulgaria

China

Colombia

Croatia (Hrvatska)

Czech Republic

Denmark

Estonia

Finland

Germany

Greece

Hong Kong

Hungary

Iceland

Iran

Ireland

Israel

Italy

Kuwait

Lithuania

Luxembourg

Malaysia

Malta

Netherlands

Norway

Oman

Peru

Philippines

Poland

Portugal

Qatar

Romania

Serbia

Singapore

Slovakia

Slovenia

Spain

Sri Lanka

Sweden

Thailand

Turkey

United Arab Emirates

United Kingdom

International Drug Name Search

Glossary

SPC

Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday 25 August 2011

Bisogamma

Bisogamma may be available in the countries listed below.

Ingredient matches for Bisogamma

Bisoprolol

Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Bisogamma in the following countries:

Bulgaria

Czech Republic

Georgia

Germany

Hungary

Poland

Romania

Russian Federation

Slovakia

International Drug Name Search

Saturday 20 August 2011

Loperamid Helvepharm

Loperamid Helvepharm may be available in the countries listed below.

Ingredient matches for Loperamid Helvepharm

Loperamide

Loperamide hydrochloride (a derivative of Loperamide) is reported as an ingredient of Loperamid Helvepharm in the following countries:

Switzerland

International Drug Name Search

Formic Acid

In some countries, this medicine may only be approved for veterinary use.

CAS registry number (Chemical Abstracts Service)

0000064-18-6

Chemical Formula

C-H2-O2

Molecular Weight

Therapeutic Category

Antiparasitic agent

Chemical Name

Methanoic Acid (IUPAC)

Foreign Names

Acidum formicum (Latin)
Ameisensäure (German)
Acide formique (French)
Ácido fórmico (Spanish)

Generic Names

Aminic Acid (IS)
C1 acid (IS)
CCRIS 6039 (IS)
E236 (IS)
EPA Pesticide Chemical Code 214900 (IS)
Formylic Acid (IS)
Hydrogencarboxylic Acid (IS)
Acidum formicicum (PH: ÖAB 2009)
Ameisensäure (PH: ÖAB 2009)

Brand Name

Ameisensäure 60% ad us. vet. (veterinary use)
Serumber, Germany

International Drug Name Search

Glossary

IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
PH	Pharmacopoeia Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Microzide

Microzide is a brand name of hydrochlorothiazide, approved by the FDA in the following formulation(s):

MICROZIDE (hydrochlorothiazide - capsule; oral)

Manufacturer: WATSON LABS

Approval date: December 27, 1996

Strength(s): 12.5MG ^[RLD]^[AB]

Has a generic version of Microzide been approved?

Yes. The following products are equivalent to Microzide:

hydrochlorothiazide capsule; oral

Manufacturer: ALEMBIC PHARMS LTD

Approval date: November 30, 2010

Strength(s): 12.5MG ^[AB]

Manufacturer: APOTEX

Approval date: May 16, 2008

Strength(s): 12.5MG ^[AB]

Manufacturer: AUROBINDO PHARMA

Approval date: September 18, 2007

Strength(s): 12.5MG ^[AB]

Manufacturer: IPCA LABS LTD

Approval date: April 2, 2009

Strength(s): 12.5MG ^[AB]

Manufacturer: IVAX SUB TEVA PHARMS

Approval date: July 13, 2005

Strength(s): 12.5MG ^[AB]

Manufacturer: JUBILANT CADISTA

Approval date: February 11, 2008

Strength(s): 12.5MG ^[AB]

Manufacturer: LANNETT HOLDINGS INC

Approval date: January 27, 2012

Strength(s): 12.5MG ^[AB]

Manufacturer: MYLAN

Approval date: January 28, 2000

Strength(s): 12.5MG ^[AB]

Manufacturer: UNICHEM

Approval date: January 19, 2010

Strength(s): 12.5MG ^[AB]

Manufacturer: VINTAGE PHARMS

Approval date: September 17, 2002

Strength(s): 12.5MG ^[AB]

Manufacturer: WEST WARD

Approval date: November 26, 2007

Strength(s): 12.5MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Microzide. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

Related Patents

There are no current U.S. patents associated with Microzide.

Friday 12 August 2011

Isotretinoin-ratiopharm

Isotretinoin-ratiopharm may be available in the countries listed below.

Ingredient matches for Isotretinoin-ratiopharm

Isotretinoin

Isotretinoin is reported as an ingredient of Isotretinoin-ratiopharm in the following countries:

Austria

Finland

Germany

Hungary

International Drug Name Search

Thursday 11 August 2011

Tolfedine

Tolfedine may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Tolfedine

Tolfenamic Acid

Tolfenamic Acid is reported as an ingredient of Tolfedine in the following countries:

Australia

Austria

Belgium

Germany

Ireland

Italy

Luxembourg

Netherlands

Portugal

Sweden

Switzerland

United Kingdom

International Drug Name Search

Wednesday 10 August 2011

Topicort

TOPICORT (desoximetasone - cream; topical)

Manufacturer: TARO PHARMS NORTH

Approved Prior to Jan 1, 1982

Strength(s): 0.25% ^[RLD]^[AB]

TOPICORT (desoximetasone - gel; topical)

Manufacturer: TARO PHARMS NORTH

Approval date: March 29, 1982

Strength(s): 0.05% ^[RLD]^[AB]

TOPICORT (desoximetasone - ointment; topical)

Manufacturer: TARO PHARMS NORTH

Approval date: September 30, 1983

Strength(s): 0.25% ^[RLD]^[AB]

Manufacturer: TARO PHARMS NORTH

Approval date: January 17, 1985

Strength(s): 0.05% ^[RLD]

Has a generic version of Topicort been approved?

Yes. The following products are equivalent to Topicort:

desoximetasone cream; topical

Manufacturer: FOUGERA PHARMS

Approval date: June 29, 2010

Strength(s): 0.25% ^[AB]

Manufacturer: PERRIGO NEW YORK

Approval date: July 1, 2003

Strength(s): 0.25% ^[AB]

Manufacturer: TARO

Approval date: November 30, 1990

Strength(s): 0.25% ^[AB]

desoximetasone gel; topical

Manufacturer: PERRIGO NEW YORK

Approval date: January 9, 2006

Strength(s): 0.05% ^[AB]

Manufacturer: TARO

Approval date: July 14, 1998

Strength(s): 0.05% ^[AB]

Manufacturer: VERSAPHARM

Approval date: March 10, 2011

Strength(s): 0.05% ^[AB]

desoximetasone ointment; topical

Manufacturer: TARO

Approval date: June 7, 1996

Strength(s): 0.25% ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Topicort. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

Related Patents

There are no current U.S. patents associated with Topicort.

Sunday 7 August 2011

Tramadol Eel

Tramadol Eel may be available in the countries listed below.

Ingredient matches for Tramadol Eel

Tramadol

Tramadol is reported as an ingredient of Tramadol Eel in the following countries:

Romania

International Drug Name Search

Monday 1 August 2011

Oméprazole Gerda

Oméprazole Gerda may be available in the countries listed below.

Ingredient matches for Oméprazole Gerda

Omeprazole

Omeprazole is reported as an ingredient of Oméprazole Gerda in the following countries:

France

International Drug Name Search

Sunday 31 July 2011

Fonzylane

Fonzylane may be available in the countries listed below.

Ingredient matches for Fonzylane

Buflomedil

Buflomedil is reported as an ingredient of Fonzylane in the following countries:

Tunisia

Buflomedil hydrochloride (a derivative of Buflomedil) is reported as an ingredient of Fonzylane in the following countries:

France

International Drug Name Search

Monday 25 July 2011

Temodal

Temodal may be available in the countries listed below.

UK matches:

Temodal Capsules (SPC)

Ingredient matches for Temodal

Temozolomide

Temozolomide is reported as an ingredient of Temodal in the following countries:

Argentina

Australia

Austria

Bahrain

Belgium

Brazil

Bulgaria

Canada

Chile

Colombia

Costa Rica

Croatia (Hrvatska)

Czech Republic

Denmark

Dominican Republic

Ecuador

Egypt

El Salvador

Finland

France

Georgia

Germany

Greece

Guatemala

Honduras

Hong Kong

Hungary

Iceland

Indonesia

Iran

Iraq

Ireland

Israel

Italy

Japan

Jordan

Kuwait

Lebanon

Luxembourg

Malaysia

Mexico

Netherlands

New Zealand

Nicaragua

Norway

Oman

Panama

Peru

Philippines

Poland

Qatar

Romania

Russian Federation

Saudi Arabia

Serbia

Singapore

Slovakia

Slovenia

South Africa

Spain

Sweden

Switzerland

Syria

Taiwan

Thailand

Turkey

United Arab Emirates

United Kingdom

Venezuela

Yemen

International Drug Name Search

Glossary

SPC

Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Coniel

Coniel may be available in the countries listed below.

Ingredient matches for Coniel

Benidipine

Benidipine hydrochloride (a derivative of Benidipine) is reported as an ingredient of Coniel in the following countries:

China

Georgia

Japan

Philippines

Turkey

International Drug Name Search

Thursday 14 July 2011

Chloramin T-Lysoform

Chloramin T-Lysoform may be available in the countries listed below.

Ingredient matches for Chloramin T-Lysoform

Tosylchloramide Sodium

Tosylchloramide Sodium trihydrate (a derivative of Tosylchloramide Sodium) is reported as an ingredient of Chloramin T-Lysoform in the following countries:

Germany

International Drug Name Search

Sunday 10 July 2011

Tiropramide

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A03AC05

CAS registry number (Chemical Abstracts Service)

0055837-29-1

Chemical Formula

C28-H41-N3-O3

Molecular Weight

467

Therapeutic Category

Antispasmodic agent

Chemical Name

Benzenepropanamide, α-(benzoylamino)-4-[2-(diethylamino)ethoxy]-N,N-dipropyl-, (±)-

Foreign Names

Tiropramidum (Latin)
Tiropramid (German)
Tiropramide (French)
Tiropramida (Spanish)

Generic Names

Tiropramide (OS: DCIT, DCF)
CR 605 (IS)

Brand Names

Alfospas
Korea United Pharm, Vietnam; Rottapharm, Italy

Maiorad
Delta, Portugal; Rotta Pharmaceuticals, Dominican Republic; Rotta Pharmaceuticals, Guatemala; Rotta Pharmaceuticals, Honduras; Rotta Pharmaceuticals, Haiti; Rotta Pharmaceuticals, Panama; Rotta Pharmaceuticals, El Salvador; Rotta Pharmaceuticals, Thailand; Rottapharm, Italy; Rottapharm, Vietnam

Tiram
Shinpoong Daewoo, Vietnam

International Drug Name Search

Glossary

DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday 8 July 2011

Anzatax

Anzatax may be available in the countries listed below.

Ingredient matches for Anzatax

Clonazepam

Clonazepam is reported as an ingredient of Anzatax in the following countries:

Peru

Paclitaxel

Paclitaxel is reported as an ingredient of Anzatax in the following countries:

Australia

Hong Kong

Indonesia

Italy

Latvia

Lithuania

Malaysia

Singapore

South Africa

Taiwan

Turkey

International Drug Name Search

Thursday 7 July 2011

Miotenk

Miotenk may be available in the countries listed below.

Ingredient matches for Miotenk

Amiodarone

Amiodarone hydrochloride (a derivative of Amiodarone) is reported as an ingredient of Miotenk in the following countries:

Argentina

International Drug Name Search

Sunday 26 June 2011

Colistimetato sodico

Colistimetato sodico may be available in the countries listed below.

Ingredient matches for Colistimetato sodico

Colistin Sulfate

Colistimetato sodico (DCIT) is known as Colistin Sulfate in the US.

International Drug Name Search

Glossary

DCIT

Denominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Eronix

Eronix may be available in the countries listed below.

Ingredient matches for Eronix

Erythromycin

Erythromycin is reported as an ingredient of Eronix in the following countries:

Bangladesh

International Drug Name Search

Friday 24 June 2011

Oforta

Pronunciation: floo-DAYR-a-been
Generic Name: Fludarabine
Brand Name: Oforta

Some patients who received high doses of Oforta to treat acute leukemia developed severe nervous system side effects, including blindness, coma, and death. Similar nervous system side effects, including coma, seizures, agitation, and confusion, have occurred in patients at doses recommended for the treatment of chronic lymphocytic leukemia. Discuss any questions or concerns with your doctor. Contact your doctor right away if any of these effects occur.

Oforta may severely decrease bone marrow function. This can lower your body's ability to fight infection and reduce the ability of your blood to clot properly. Some patients have developed severe and sometimes fatal blood problems (eg, hemolytic anemia, autoimmune thrombocytopenia, hemophilia) while using Oforta. Your doctor will need to monitor you closely for these conditions. Tell your doctor right away if you develop signs or symptoms of an infection (eg, swollen glands, sore throat, fever, chills), bleeding problems (eg, easy bruising; black, tarry stools; bleeding from the gums), or hemolytic anemia (eg, yellowing of eyes or skin, dark urine, severe tiredness or weakness). Be sure to keep all doctor and laboratory appointments.

Fatal lung problems have been reported in patients receiving Oforta along with pentostatin. Oforta is not recommended for use with pentostatin.

Oforta is used for:

Treating patients with certain types of leukemia who have not responded to other therapy or whose disease has progressed during treatment with other medicines. It may also be used for other conditions as determined by your doctor.

Oforta is an antimetabolite. It works by preventing the cancer cell from reproducing, which results in death of the cell.

Do NOT use Oforta if:

you are allergic to any ingredient in Oforta

you are taking pentostatin

Contact your doctor or health care provider right away if any of these apply to you.

Before using Oforta:

Some medical conditions may interact with Oforta. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

if you are pregnant, planning to become pregnant, or are breast-feeding

if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

if you have allergies to medicines, foods, or other substances

if you have a history of bone marrow problems, blood or bleeding problems, kidney problems, immune system problems, nervous system problems, infections, or skin cancer

if you receive other chemotherapy, radiation therapy, or you have received radiation or chemotherapy in the past

if you will be having a blood transfusion

Some MEDICINES MAY INTERACT with Oforta. Tell your health care provider if you are taking any other medicines, especially any of the following:

Pentostatin because the risk of fatal lung problems may be increased

Digoxin because its effectiveness may be decreased by Oforta

This may not be a complete list of all interactions that may occur. Ask your health care provider if Oforta may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Oforta:

Use Oforta as directed by your doctor. Check the label on the medicine for exact dosing instructions.

An extra patient leaflet is available with Oforta. Talk to your pharmacist if you have questions about this information.

Take Oforta by mouth with or without food. Take it with plenty of water.

Swallow Oforta whole. Do not break, crush, chew, or hold it in your mouth before swallowing.

Do not remove the tablet from the blister until immediately before you take your dose. Push the tablet through the foil to remove it from the blister.

Ask your doctor how you should safely handle Oforta. Do not get Oforta on your skin. If contact occurs, wash well with soap and water. Tell your doctor if you develop a skin reaction from Oforta.

Do not get any dust from Oforta in your eyes or nose. If contact occurs, rinse immediately with gently flowing water for at least 15 minutes. Tell your doctor if you get Oforta in your eyes.

If you no longer need Oforta, do not throw it in the trash. Ask your doctor or pharmacist how to safely dispose of it.

If you miss a dose of Oforta, contact your doctor right away.

Ask your health care provider any questions you may have about how to use Oforta.

Important safety information:

Oforta may cause drowsiness, dizziness, tiredness, weakness, vision problems, confusion, agitation, or seizures. Some of these effects may be worse if you take it with alcohol or certain medicines. Use Oforta with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

If vomiting or diarrhea occurs, you will need to take care not to become dehydrated. Contact your doctor for instructions.

Oforta may reduce the number of clot-forming cells (platelets) in your blood. Avoid activities that may cause bruising or injury. Tell your doctor if you have unusual bruising or bleeding. Tell your doctor if you have dark, tarry, or bloody stools.

Oforta may lower the ability of your body to fight infection and may increase the risk of severe and sometimes fatal infection. Avoid contact with people who have colds or infections. Tell your doctor if you notice signs of infection like fever, sore throat, rash, or chills.

Do not receive a live vaccine (eg, measles, mumps) during or after treatment with Oforta. Talk with your doctor before you receive any vaccine.

New or worsening skin cancer has been reported with Oforta. Tell your doctor if you have a history of skin cancer. Contact your doctor right away if you notice a change in the appearance of a mole, new growth on the skin, or any unusual skin change.

A severe and possibly fatal nervous system problem (progressive multifocal leukoencephalopathy [PML]) has been reported in patients who use Oforta. This has been reported to develop between a few weeks and as long as about 1 year after starting treatment. Many of these patients were also taking other chemotherapy or had received other chemotherapy in the past. Contact your doctor right away if you develop signs of PML, such as trouble walking or talking, confusion, vision problems, or vision loss.

Men who may father a child and women who may become pregnant must use an effective form of birth control while using Oforta and for 6 months after stopping treatment. If you have questions about effective birth control, talk with your doctor.

Lab tests, including complete blood cell counts, may be performed while you use Oforta. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

Oforta should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

PREGNANCY and BREAST-FEEDING: Oforta has been shown to cause harm to the fetus. Avoid becoming pregnant while you use it and for 6 months after you stop treatment. If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of using Oforta while you are pregnant. It is not known if Oforta is found in breast milk. Do not breast-feed while taking Oforta.

Possible side effects of Oforta:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Diarrhea; general body discomfort; increased sweating; loss of appetite; muscle pain; nausea; sinus inflammation; stuffy nose; tiredness; vomiting; weakness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); abnormal thinking; black, tarry, or bloody stools; blood in the urine; changes in strength or the way you walk; chest pain; confusion; coughing or vomiting blood; dark urine; difficult or painful urination; fainting; hearing loss; irregular heartbeat; lower back or side pain; mental or mood changes (eg, agitation, confusion); muscle weakness or cramps; numbness or tingling in the hands or feet; red, swollen, blistered, or peeling skin; seizures; severe or persistent tiredness or weakness; shortness of breath; signs of infection (eg, fever, chills, cough, or sore throat); skin changes; sores on the mouth or lips; swelling of the fingers, hands, or feet; unusual bruising or bleeding; vision changes or blindness; vomit that looks like coffee grounds; yellowing of the eyes or skin.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Oforta side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include bleeding; blindness; coma; infection.

Proper storage of Oforta:

Store Oforta at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Oforta out of the reach of children and away from pets.

General information:

If you have any questions about Oforta, please talk with your doctor, pharmacist, or other health care provider.

Oforta is to be used only by the patient for whom it is prescribed. Do not share it with other people.

If your symptoms do not improve or if they become worse, check with your doctor.

Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Oforta. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

More Oforta resources

Oforta Side Effects (in more detail)
Oforta Dosage
Oforta Use in Pregnancy & Breastfeeding
Oforta Drug Interactions
Oforta Support Group
0 Reviews for Oforta - Add your own review/rating

Oforta Consumer Overview

Oforta Advanced Consumer (Micromedex) - Includes Dosage Information

Oforta Prescribing Information (FDA)

Fludarabine Prescribing Information (FDA)

Fludara Monograph (AHFS DI)

Fludara Advanced Consumer (Micromedex) - Includes Dosage Information

Fludara Prescribing Information (FDA)

Compare Oforta with other medications

Chronic Lymphocytic Leukemia
Leukemia
Non-Hodgkin's Lymphoma

Sunday 19 June 2011

Diclofenac Retard-Sandoz

Diclofenac Retard-Sandoz may be available in the countries listed below.

Ingredient matches for Diclofenac Retard-Sandoz

Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclofenac Retard-Sandoz in the following countries:

Luxembourg

International Drug Name Search

Monday 6 June 2011

Rhoxal-Estradiol Derm 50

Generic Name: estrogen (Oral route, Parenteral route, Topical application route, Transdermal route)

Commonly used brand name(s)

In the U.S.

Alora

Cenestin

Climara

Divigel

Elestrin

Emcyt

Enjuvia

Esclim

Estinyl

EstroGel

Evamist

Femtrace

Gynodiol

Menest

Menostar

Ogen .625

Ogen 1.25

Ogen 2.5

Premarin

Vivelle

Vivelle-Dot

In Canada

Estraderm

Estradot Transdermal

Estradot Transdermal Therapeutic System

Estradot Transdermal Therapeutic System

Estrogel

Oesclim

Rhoxal-Estradiol Derm 50

Rhoxal-Estradiol Derm 75

Roxal-Estradiol Derm 100

Vivelle 100 Mcg

Vivelle 25 Mcg

Available Dosage Forms:

Tablet

Patch, Extended Release

Gel/Jelly

Spray

Emulsion

Tablet, Enteric Coated

Capsule

Uses For Rhoxal-Estradiol Derm 50

Estrogens are female hormones. They are produced by the body and are necessary for the normal sexual development of the female and for the regulation of the menstrual cycle during the childbearing years.

The ovaries begin to produce less estrogen after menopause (the change of life). This medicine is prescribed to make up for the lower amount of estrogen. Estrogens help relieve signs of menopause, such as hot flashes and unusual sweating, chills, faintness, or dizziness.

Estrogens are prescribed for several reasons:

To provide additional hormone when the body does not produce enough of its own, such as during menopause or when female puberty (development of female sexual organs) does not occur on time. Other conditions include a genital skin condition (vulvar atrophy), inflammation of the vagina (atrophic vaginitis), or ovary problems (female hypogonadism or failure or removal of both ovaries).

To help prevent weakening of bones (osteoporosis) in women past menopause.

In the treatment of selected cases of breast cancer in men and women.

In the treatment of cancer of the prostate in men.

Estrogens may also be used for other conditions as determined by your doctor.

There is no medical evidence to support the belief that the use of estrogens will keep the patient feeling young, keep the skin soft, or delay the appearance of wrinkles. Nor has it been proven that the use of estrogens during menopause will relieve emotional and nervous symptoms, unless these symptoms are caused by other menopausal symptoms, such as hot flashes or hot flushes.

Estrogens are available only with your doctor's prescription.

Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, estrogen is used in certain patients with the following medical conditions:

Gender identity disorder, male-to-female transsexualism (person who is born as a man but adapts to a woman's lifestyle, sees himself as a woman, and feels like a woman instead of a man.

Osteoporosis caused by lack of estrogen before menopause.

Turner's syndrome (a genetic disorder).

Before Using Rhoxal-Estradiol Derm 50

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to medicines in this group or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Use of this medicine before puberty is not recommended. Growth of bones can be stopped early. Girls and boys may develop growth of breasts. Girls may have vaginal changes, including vaginal bleeding.

This medicine may be used to start puberty in teenagers with some types of delayed puberty.

Geriatric

Elderly people are especially sensitive to the effects of estrogens. This may increase the chance of side effects during treatment, especially stroke, invasive breast cancer, and memory problems.

Pregnancy

Estrogens are not recommended for use during pregnancy or right after giving birth. Becoming pregnant or maintaining a pregnancy is not likely to occur around the time of menopause.

Certain estrogens have been shown to cause serious birth defects in humans and animals. Some daughters of women who took diethylstilbestrol (DES) during pregnancy have developed reproductive (genital) tract problems and, rarely, cancer of the vagina or cervix (opening to the uterus) when they reached childbearing age. Some sons of women who took DES during pregnancy have developed urinary-genital tract problems.

Breast Feeding

Use of this medicine is not recommended in nursing mothers. Estrogens pass into the breast milk and their possible effect on the baby is not known.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking any of these medicines, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using medicines in this class with any of the following medicines is not recommended. Your doctor may decide not to treat you with a medication in this class or change some of the other medicines you take.

Rotavirus Vaccine, Live

Using medicines in this class with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

Adenovirus Vaccine Type 4, Live

Adenovirus Vaccine Type 7, Live

Bacillus of Calmette and Guerin Vaccine, Live

Boceprevir

Felbamate

Influenza Virus Vaccine, Live

Isotretinoin

Measles Virus Vaccine, Live

Mumps Virus Vaccine, Live

Paclitaxel

Paclitaxel Protein-Bound

Rotavirus Vaccine, Live

Rubella Virus Vaccine, Live

Smallpox Vaccine

St John's Wort

Theophylline

Tizanidine

Tranexamic Acid

Typhoid Vaccine

Varicella Virus Vaccine

Yellow Fever Vaccine

Interactions with Food/Tobacco/Alcohol

Proper Use of estrogen

This section provides information on the proper use of a number of products that contain estrogen. It may not be specific to Rhoxal-Estradiol Derm 50. Please read with care.

Take this medicine only as directed by your doctor. Do not take more of it and do not take or use it for a longer time than your doctor ordered. For patients taking any of the estrogens by mouth, try to take the medicine at the same time each day to reduce the possibility of side effects and to allow it to work better.

This medicine usually comes with patient information or directions. Read and follow the instructions in the insert carefully. Ask your doctor if you have any questions.

For patients taking any of the estrogens by mouth or by injection:

Nausea may occur during the first few weeks after you start taking estrogens. This effect usually disappears with continued use. If the nausea is bothersome, it can usually be prevented or reduced by taking each dose with food or immediately after food.

For patients using the transdermal (skin patch):

Wash and dry your hands thoroughly before and after handling the patch.

Apply the patch to a clean, dry, non-oily skin area of your lower abdomen, hips below the waist, or buttocks that has little or no hair and is free of cuts or irritation. The manufacturer of the 0.025-mg patch recommends that its patch be applied to the buttocks only. Furthermore, each new patch should be applied to a new site of application. For instance, if the old patch is taken off the left buttock, then apply the new patch to the right buttock.

Do not apply to the breasts. Also, do not apply to the waistline or anywhere else where tight clothes may rub the patch loose.

Press the patch firmly in place with the palm of your hand for about 10 seconds. Make sure there is good contact, especially around the edges.

If a patch becomes loose or falls off, you may reapply it or discard it and apply a new patch.

Each dose is best applied to a different area of skin on your lower abdomen, hips below the waist, or buttocks so that at least 1 week goes by before the same area is used again. This will help prevent skin irritation.

For patients using the topical emulsion (skin lotion):

Washing and drying hands thoroughly before each application.

Apply while you are sitting comfortably. Apply one pouch to each leg every morning.

Apply the entire contents of one pouch to clean, dry skin on the left thigh. Rub the emulsion into the entire thigh and calf for 3 minutes until thoroughly absorbed.

Apply entire contents of the second pouch to clean, dry skin on the right thigh. Rub the emulsion into the entire thigh and calf for 3 minutes until thoroughly absorbed.

Rub any remaining emulsion on both hands on the buttocks.

Washing and drying hands thoroughly after application.

To avoid transfer to other individuals, allow the application areas to dry completely before covering with clothing.

If you are using the Evamist® transdermal spray:

Spray the medicine on your skin on the inside of your forearm, between the elbow and the wrist.

Do not allow your child to touch the area of the arm where the medicine was sprayed. If you cannot avoid to come nearer with your child, wear clothes with long sleeves to cover the application site.

If your child comes in direct contact with the arm where the medicine was sprayed, wash your child's skin right away with soap and water.

Do not allow your pets to lick or touch the arm where the medicine was sprayed.

Dosing

The dose medicines in this class will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of these medicines. If your dose is different, do not change it unless your doctor tells you to do so.

For conjugated estrogens

For oral dosage form (tablets):
- For treating breast cancer in women after menopause and in men:
  - Adults—10 milligrams (mg) three times a day for at least 3 months.
- For treating a genital skin condition (vulvar atrophy), inflammation of the vagina (atrophic vaginitis), or symptoms of menopause:
  - Adults—0.3 milligram (mg) a day. Your doctor may want you to take the medicine each day or only on certain days of the month. Your doctor may change the dose based on how your body responds to the medication.
- To prevent loss of bone (osteoporosis):
  - Adults—0.3 milligram (mg) a day. Your doctor may want you to take the medicine each day or only on certain days of the month. Your doctor may change the dose based on how your body responds to the medication.
- For treating ovary problems (female hypogonadism or for starting puberty):
  - Adults and teenagers—0.3 to 0.625 milligram (mg) a day. Your doctor may want you to take the medicine only on certain days of the month.
- For treating ovary problems (failure or removal of both ovaries):
  - Adults—1.25 milligram (mg) a day. Your doctor may want you to take the medicine each day or only on certain days of the month.
- For treating prostate cancer:
  - Adults—1.25 to 2.5 milligram (mg) three times a day.

For injection dosage form:
- For controlling abnormal bleeding of the uterus:
  - Adults—25 milligrams (mg) injected into a muscle or vein. This may be repeated in six to twelve hours if needed.

For esterified estrogens

For oral dosage form (tablets):
- For treating breast cancer in women after menopause and in men:
  - Adults—10 milligrams (mg) three times a day for at least three months.
- For treating a genital skin condition (vulvar atrophy) or inflammation of the vagina (atrophic vaginitis), or to prevent loss of bone (osteoporosis):
  - Adults—0.3 to 1.25 mg a day. Your doctor may want you to take the medicine each day or only on certain days of the month.
- For treating ovary problems (failure or removal of both ovaries):
  - Adults—1.25 mg a day. Your doctor may want you to take the medicine each day or only on certain days of the month.
- For treating ovary problems (female hypogonadism):
  - Adults—2.5 to 7.5 mg a day. This dose may be divided up and taken in smaller doses. Your doctor may want you to take the medicine each day or only on certain days of the month.
- For treating symptoms of menopause:
  - Adults—0.625 to 1.25 mg a day. Your doctor may want you to take the medicine each day or only on certain days of the month.
- For treating prostate cancer:
  - Adults—1.25 to 2.5 mg three times a day.

For estradiol

For oral dosage form:
- For treating breast cancer in women after menopause and in men:
  - Adults—10 milligrams (mg) three times a day for at least 3 months.
- For treating a genital skin condition (vulvar atrophy), inflammation of the vagina (atrophic vaginitis), ovary problems (female hypogonadism or failure or removal of both ovaries), or symptoms of menopause:
  - Adults—At first, 1 to 2 milligrams (mg) one time per day for at least 3 months. Your doctor may want you to take the medicine each day or only on certain days of the month. Your doctor may also need to change the dose based on how your body responds to the medication.
- For treating prostate cancer:
  - Adults—1 to 2 milligrams (mg) three times a day.
- To prevent loss of bone (osteoporosis):
  - Adults—0.5 milligram (mg) a day. Your doctor may want you to take the medicine each day or only on certain days of the month.

For topical emulsion dosage form (skin lotion):
- For treating symptoms of menopause:
  - Adults—1.74 grams (one pouch) applied to the skin of each leg (thigh and calf) once a day in the morning.

For transdermal dosage form (skin patches):
- For treating a genital skin condition (vulvar atrophy), inflammation of the vagina (atrophic vaginitis), symptoms of menopause, ovary problems (female hypogonadism or failure or removal of both ovaries), or to prevent loss of bone (osteoporosis):
  - For the Climara patches
  - Adults—0.025 to 0.1 milligram (mg) (one patch) applied to the skin and worn for one week. Then, remove that patch and apply a new one. A new patch should be applied once a week for three weeks. During the fourth week, you may or may not wear a patch. Your health care professional will tell you what you should do for this fourth week. After the fourth week, you will repeat the cycle.
  - For the Alora, Estraderm, Estradot, Vivelle, or Vivelle-Dot patches
  - Adults—0.025 to 0.1 mg (one patch) applied to the skin and worn for one half of a week. Then, remove that patch and apply and wear a new patch for the rest of the week. A new patch should be applied two times a week for three weeks. During the fourth week, you may or may not apply new patches. Your health care professional will tell you what you should do for this fourth week. After the fourth week, you will repeat the cycle.

For estradiol cypionate

For injection dosage form:
- For treating ovary problems (female hypogonadism):
  - Adults—1.5 to 2 milligrams (mg) injected into a muscle once a month.
- For treating symptoms of menopause:
  - Adults—1 to 5 milligrams (mg) injected into a muscle every 3 to 4 weeks.

For estradiol valerate

For injection dosage form:
- For treating a genital skin condition (vulvar atrophy), inflammation of the vagina (atrophic vaginitis), symptoms of menopause, or ovary problems (female hypogonadism or failure or removal of both ovaries):
  - Adults—10 to 20 milligrams (mg) injected into a muscle every 4 weeks as needed.
- For treating prostate cancer:
  - Adults—30 milligrams (mg) injected into a muscle every 1 or 2 weeks.

For estrone

For injection dosage form:
- For controlling abnormal bleeding of the uterus:
  - Adults—2 to 5 milligrams (mg) a day, injected into a muscle for several days.
- For treating a genital skin condition (vulvar atrophy), inflammation of the vagina (atrophic vaginitis), or symptoms of menopause:
  - Adults—0.1 to 0.5 milligram (mg) injected into a muscle 2 or 3 times a week. Your doctor may want you to receive the medicine each week or only during certain weeks of the month.
- For treating ovary problems (female hypogonadism or failure or removal of both ovaries):
  - Adults—0.1 to 1 milligram (mg) a week. This is injected into a muscle as a single dose or divided into more than one dose. Your doctor may want you to receive the medicine each week or only during certain weeks of the month.
- For treating prostate cancer:
  - Adults—2 to 4 milligrams (mg) injected into a muscle 2 or 3 times a week.

For estropipate

For oral dosage form (tablets):
- For treating a genital skin condition (vulvar atrophy), inflammation of the vagina (atrophic vaginitis), or symptoms of menopause:
  - Adults—0.75 to 6 milligrams (mg) a day. Your doctor may want you to take the medicine each day or only on certain days of the month.
- For treating ovary problems (female hypogonadism or failure or removal of both ovaries):
  - Adults—1.5 to 9 milligrams (mg) a day. Your doctor may want you to take the medicine each day or only on certain days of the month.
- To prevent loss of bone (osteoporosis):
  - Adults—0.75 milligram (mg) a day. Your doctor may want you to take the medicine each day for twenty-five days of a thirty-one–day cycle.

For ethinyl estradiol

For oral dosage form (tablets):
- For treating breast cancer in women after menopause and in men:
  - Adults—1 milligram (mg) three times a day.
- For treating ovary problems (female hypogonadism or failure or removal of both ovaries):
  - Adults—0.05 milligram (mg) one to three times a day for 3 to 6 months. Your doctor may want you to take the medicine each day or only on certain days of the month.
- For treating prostate cancer:
  - Adults—0.15 to 3 milligrams (mg) a day.
- For treating symptoms of menopause:
  - Adults—0.02 to 0.05 milligram (mg) a day. Your doctor may want you to take the medicine each day or only on certain days of the month.

For ethinyl estradiol and norethindrone

For oral dosage form (tablets):
- For treating symptoms of menopause:
  - Adults—1 tablet (5 mcg ethinyl estradiol and 1 mg of norethindrone) each day.
- To prevent loss of bone (osteoporosis):
  - Adults—1 tablet (5 mcg ethinyl estradiol and 1 mg of norethindrone) each day.

Missed Dose

If you miss a dose of this medicine, apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.

If you forget to wear or change a patch, put one on as soon as you can. If it is almost time to put on your next patch, wait until then to apply a new patch and skip the one you missed. Do not apply extra patches to make up for a missed dose.

Storage

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Ask your healthcare professional how you should dispose of any medicine you do not use.

Precautions While Using Rhoxal-Estradiol Derm 50

It is very important that your doctor check your progress at regular visits to make sure this medicine does not cause unwanted effects. These visits will usually be every year, but some doctors require them more often.

In some patients using estrogens, tenderness, swelling, or bleeding of the gums may occur. Brushing and flossing your teeth carefully and regularly and massaging your gums may help prevent this. See your dentist regularly to have your teeth cleaned. Check with your medical doctor or dentist if you have any questions about how to take care of your teeth and gums, or if you notice any tenderness, swelling, or bleeding of your gums.

Although the incidence is low, the use of estrogens may increase you chance of getting cancer of the breast, ovaries, or uterus (womb). Therefore, it is very important that you regularly check your breasts for any unusual lumps or discharge. Report any problems to your doctor. You should also have a mammogram (x-ray pictures of the breasts) done if your doctor recommends it. Because breast cancer has occurred in men taking estrogens, regular breast self-exams and exams by your doctor for any unusual lumps or discharge should be done.

If your menstrual periods have stopped, they may start again. This effect will continue for as long as the medicine is taken. However, if taking the continuous treatment (0.625 mg conjugated estrogens and 2.5 mg medroxyprogesterone once a day), monthly bleeding usually stops within 10 months.

Also, vaginal bleeding between your regular menstrual periods may occur during the first 3 months of use. Do not stop taking your medicine. Check with your doctor if bleeding continues for an unusually long time, if your period has not started within 45 days of your last period, or if you think you are pregnant.

Tell the doctor in charge that you are using this medicine before having any laboratory test because some results may be affected.

Check with your child's doctor right away if your child starts to have the following symptoms: nipple or breast swelling or tenderness in females, or enlargement of the breasts in males. Your child may have been exposed to Evamist® transdermal spray.

Do not allow your pets to lick or touch the arm where Evamist® transdermal spray was applied. Small pets may be sensitive to this medicine. Call your pet's veterinarian if your pet starts to have the following symptoms: nipple or breast enlargement, swelling of the vulva, or any signs of illness.

Rhoxal-Estradiol Derm 50 Side Effects

Women rarely have severe side effects from taking estrogens to replace estrogen. Discuss these possible effects with your doctor:

The prolonged use of estrogens has been reported to increase the risk of endometrial cancer (cancer of the lining of the uterus) in women after menopause. This risk seems to increase as the dose and the length of use increase. When estrogens are used in low doses for less than 1 year, there is less risk. The risk is also reduced if a progestin (another female hormone) is added to, or replaces part of, your estrogen dose. If the uterus has been removed by surgery (total hysterectomy), there is no risk of endometrial cancer.

Although the incidence is low, the use of estrogens may increase you chance of getting cancer of the breast. Breast cancer has been reported in men taking estrogens.

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

The following side effects may be caused by blood clots, which could lead to stroke, heart attack, or death. These side effects occur rarely, and, when they do occur, they occur in men treated for cancer using high doses of estrogens.

Check with your doctor immediately if any of the following side effects occur:

More common

Breast pain (in females and males)

fast heartbeat

fever

hives

hoarseness

increased breast size (in females and males)

irritation of the skin

itching of the skin

joint pain, stiffness, or swelling

rash

redness of the skin

shortness of breath

swelling of the eyelids, face, lips, hands, or feet

swelling of the feet and lower legs

tightness in the chest

troubled breathing or swallowing

weight gain (rapid)

wheezing

Less common or rare

Changes in vaginal bleeding (spotting, breakthrough bleeding, prolonged or heavier bleeding, or complete stoppage of bleeding)

chest pain

chills

cough

heavy non-menstrual vaginal bleeding

lumps in, or discharge from, breast (in females and males)

pains in the stomach, side, or abdomen

yellow eyes or skin

Rare - for males being treated for breast or prostate cancer only

Headache (sudden or severe)

loss of coordination (sudden)

loss of vision or change of vision (sudden)

pains in the chest, groin, or leg, especially in the calf of leg

shortness of breath (sudden and unexplained)

slurring of speech (sudden)

weakness or numbness in the arm or leg

Incidence not known

Abdominal or stomach bloating

abdominal or stomach cramps

acid or sour stomach

anxiety

backache

belching

blindness

blistering, peeling, or loosening of the skin

blue-yellow color blindness

blurred vision

change in vaginal discharge

changes in skin color

changes in vision

chest discomfort

clay-colored stools

clear or bloody discharge from nipple

confusion

constipation

convulsions

dark urine

decrease in the amount of urine

decreased vision

depression

diarrhea

difficulty with breathing

difficulty with speaking

dimpling of the breast skin

dizziness

double vision

dry mouth

eye pain

fainting

fluid-filled skin blisters

full feeling in upper abdomen or stomach

full or bloated feeling or pressure in the stomach

headache

heartburn

inability to move the arms, legs, or facial muscles

inability to speak

incoherent speech

increased urination

indigestion

inverted nipple

irregular heartbeats

light-colored stools

lightheadedness

loss of appetite

loss of bladder control

lump under the arm

metallic taste

migraine headache

mood or mental changes

muscle cramps in the hands, arms, feet, legs, or face

muscle pain

muscle spasm or jerking of all extremities

muscle weakness

nausea

noisy breathing

numbness or tingling of the hands, feet, or face

pain in the ankles or knees

pain or discomfort in the arms, jaw, back or neck

pain or feeling of pressure in the pelvis

pain, tenderness, swelling of the foot or leg

painful or tender cysts in the breasts

painful, red lumps under the skin, mostly on the legs

pains in the chest, groin, or legs, especially calves of the legs

partial or complete loss of vision in the eye

pelvic pain

persistent crusting or scaling of nipple

pinpoint red or purple spots on the skin

prominent superficial veins over affected area

red, irritated eyes

redness or swelling of the breast

sensitivity to the sun

severe headaches of sudden onset

skin thinness

skin warmth

slow speech

sore on the skin of the breast that does not heal

sore throat

sores, ulcers, or white spots in the mouth or on the lips

stomach discomfort, upset, or pain

sudden loss of consciousness

sudden loss of coordination

sudden onset of shortness of breath for no apparent reason

sudden onset of slurred speech

sudden vision changes

swelling of the abdominal or stomach area

swelling of the fingers or hands

thirst

tremor

unpleasant breath odor

unusual tiredness or weakness

vomiting

vomiting of blood

weight loss

More common

Abnormal growth filled with fluid or semisolid material

accidental injury

bladder pain

bloated full feeling

bloody or cloudy urine

body aches or pain

coating or white patches on tongue

congestion

cough producing mucus

decrease in amount of urine

difficult, burning, or painful urination

discouragement

dryness of the throat

ear congestion or pain

excess air or gas in the stomach or intestines

fear

feeling of warmth

feeling sad or empty

frequent urge to urinate

general feeling of discomfort or illness

headache, severe and throbbing

increased clear or white vaginal discharge

irritability

itching of the vaginal, rectal or genital areas

lack of appetite

lack or loss of strength

loss of interest or pleasure

mild dizziness

neck pain

nervousness

pain

pain during sexual intercourse

painful or difficult urination

pain or tenderness around the eyes and cheekbones

passing gas

redness of the face, neck, arms, and occasionally, upper chest

runny nose

skin irritation or redness where skin patch was worn

shivering

sleeplessness

sneezing

sore mouth or tongue

stuffy nose

sudden sweating

tender, swollen glands in the neck

thick, white vaginal discharge with no odor or with a mild odor

tiredness

trouble concentrating

trouble sleeping

unable to sleep

voice changes

Less common

Blemishes on the skin

burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings

burning or stinging of the skin

diarrhea (mild)

difficulty with moving

dizziness (mild)

increased hair growth, especially on the face

lower abdominal or stomach pain or pressure

mood or mental changes

muscle stiffness

painful cold sores or blisters on the lips, nose, eyes, or genitals

pimples

pounding in the ears

problems in wearing contact lenses

slow heartbeat

tooth or gum pain

unusual decrease in sexual desire (in males)

unusual increase in sexual desire (in females)

white or brownish vaginal discharge

Incidence not known

Abnormal turning out of cervix

changes in appetite

dull ache or feeling of pressure or heaviness in the legs

flushed, dry skin

fruit-like breath odor

increased hunger

irritability

large amount of triglyceride in the blood

leg cramps

patchy brown or dark brown discoloration of the skin

poor insight and judgment

problems with memory or speech

trouble recognizing objects

trouble thinking and planning

trouble walking

twitching, uncontrolled movements of the tongue, lips, face, arms, or legs

unexpected or excess milk flow from the breasts

Also, many women who are taking estrogens with a progestin (another female hormone) will start having monthly vaginal bleeding, similar to menstrual periods, again. This effect will continue for as long as the medicine is taken. However, monthly bleeding will not occur in women who have had the uterus removed by surgery (total hysterectomy).

This medicine may cause loss or thinning of the scalp hair in some people.

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Tuesday 6 December 2011

Ingredient matches for Foligan

Saturday 3 December 2011

Ingredient matches for Umbra MD

Saturday 5 November 2011

Ingredient matches for Bevonazole

Thursday 27 October 2011

Ingredient matches for Metadaxan

Wednesday 26 October 2011

Ingredient matches for Efcortelan Soluble

Monday 24 October 2011

Ingredient matches for MPA-beta

Friday 21 October 2011

Ingredient matches for Zecef

Monday 17 October 2011

Ingredient matches for Codeinã Fosforicã

What is Delonide (desonide topical)?

What is the most important information I should know about Delonide (desonide topical)?

What should I discuss with my healthcare provider before using Delonide (desonide topical)?

How should I use Delonide (desonide topical)?

What happens if I miss a dose?

What happens if I overdose?

What should I avoid while using Delonide (desonide topical)?

Delonide (desonide topical) side effects

What other drugs will affect Delonide (desonide topical)?

More Delonide resources

Compare Delonide with other medications

Where can I get more information?

Tuesday 11 October 2011

Commonly used brand name(s)

Uses For Revitalose-C-1000

Importance of Diet

Before Using Revitalose-C-1000

Allergies

Pediatric

Geriatric

Pregnancy

Breast Feeding

Interactions with Medicines

Interactions with Food/Tobacco/Alcohol

Other Medical Problems

Proper Use of ascorbic acid

Dosing

Missed Dose

Storage

Precautions While Using Revitalose-C-1000

Revitalose-C-1000 Side Effects

More Revitalose-C-1000 resources

Compare Revitalose-C-1000 with other medications

Friday 16 September 2011

Ingredient matches for Bluxantron

Monday 12 September 2011

Ingredient matches for Genesis Drench with Selenium

Friday 9 September 2011

Ingredient matches for Winfinas

Tuesday 6 September 2011

Ingredient matches for Oxazepam AL

Topics under Neoplasia

Drug List:

Thursday 1 September 2011

Ingredient matches for Carvidon

Friday 26 August 2011

Ingredient matches for Seroxat

Thursday 25 August 2011

Ingredient matches for Bisogamma

Saturday 20 August 2011

Ingredient matches for Loperamid Helvepharm

CAS registry number (Chemical Abstracts Service)

Chemical Formula

Molecular Weight

Therapeutic Category

Chemical Name

Foreign Names

Generic Names

Brand Name

MICROZIDE (hydrochlorothiazide - capsule; oral)

Has a generic version of Microzide been approved?

hydrochlorothiazide capsule; oral

Related Patents

See also...